ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

ANI Pharmaceuticals, Inc. (ANIP)

Nasdaq · Common stock · Pharmaceutical Preparations

$72.24-0.43 (-0.59%)

As of Oct 21, 4:00 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow ANIP in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on ANIP and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free ANIP chart →

ANIP at a glance

Key statistics

$1.67B

Market capitalization

Previous close
$72.67
Open
$72.44
Day range
$71.80 – $73.51
Volume
345.0K
Average volume (30 sessions)
396.2K
Shares outstanding
22.96M
Price / earnings
16.8
Earnings per share
$4.34
Price / book
2.8
Price / sales
1.7
Dividend yield
0.02%
Beta (1 year, vs SPY)
0.27

Where the price sits in its year

52-week range

10% of the range

Below the 52-week high
-25.5%
Above the 52-week low
+3.8%

Completed sessions through Oct 21, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$72.59-0.5%
50-day average
$73.51-1.7%
200-day average
$77.95-7.3%
RSI (14)47.1

Between the conventional 30 and 70 bands.

+3.0%

1 week

-7.3%

1 month

-8.0%

3 months

-8.5%

Year to date

-24.1%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with ANIP

From the public news wire

ANIP headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →
  • Lalwani Nikhil

    −5.4K

    PRESIDENT & CEO, Director · Open-market sale

    $388.21K · Oct 15, 2026

  • Cook Meredith

    −500

    SR. VP, GENERAL COUNSEL & SEC. · Open-market sale

    $36.80K · Oct 13, 2026

  • CAREY STEPHEN P.

    −2.9K

    SVP & CFO · Open-market sale

    $208.05K · Sep 29, 2026

  • Lalwani Nikhil

    −5.4K

    PRESIDENT & CEO, Director · Open-market sale

    $383.40K · Sep 15, 2026

  • Cook Meredith

    −500

    SR. VP, GENERAL COUNSEL & SEC. · Open-market sale

    $35.40K · Sep 14, 2026

  • Thoma Jeanne

    −1.0K

    Director · Open-market sale

    $71.53K · Sep 11, 2026

  • CAREY STEPHEN P.

    −2.9K

    SVP & CFO · Open-market sale

    $207.48K · Aug 31, 2026

  • Gosebruch Henry O

    +6.7K

    Director · Grant or award

    · Aug 19, 2026

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
Princeton, NJ
Employees
970
Listed since
Sep 13, 1999
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.